D. Harms

1.3k total citations
41 papers, 714 citations indexed

About

D. Harms is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, D. Harms has authored 41 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in D. Harms's work include Testicular diseases and treatments (8 papers), Neuroblastoma Research and Treatments (8 papers) and Sarcoma Diagnosis and Treatment (7 papers). D. Harms is often cited by papers focused on Testicular diseases and treatments (8 papers), Neuroblastoma Research and Treatments (8 papers) and Sarcoma Diagnosis and Treatment (7 papers). D. Harms collaborates with scholars based in Germany, Austria and Netherlands. D. Harms's co-authors include U. Göbel, D. Schmidt, Gabriele Calaminus, H. Spaar, Dieter Körholz, R. Haas, Ulrike Graubner, O. D. Wiestler, Rob Pieters and M. Bamberg and has published in prestigious journals such as Journal of Clinical Oncology, Leukemia and European Journal of Pediatrics.

In The Last Decade

D. Harms

40 papers receiving 690 citations

Peers

D. Harms
H. Spaar Germany
Mark Nesbit United States
Robert E. Hittle United States
Jacques Otten Belgium
F. B. Ruymann United States
Yasunori Toyoda Japan
Batia Stark Israel
Marilyn Sonley Canada
Rebecca Byrd United States
Monika Csóka Hungary
H. Spaar Germany
D. Harms
Citations per year, relative to D. Harms D. Harms (= 1×) peers H. Spaar

Countries citing papers authored by D. Harms

Since Specialization
Citations

This map shows the geographic impact of D. Harms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Harms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Harms more than expected).

Fields of papers citing papers by D. Harms

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Harms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Harms. The network helps show where D. Harms may publish in the future.

Co-authorship network of co-authors of D. Harms

This figure shows the co-authorship network connecting the top 25 collaborators of D. Harms. A scholar is included among the top collaborators of D. Harms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Harms. D. Harms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Göbel, U., et al.. (2010). Telemicroscopic Conferences for Children of the Perm Territory with Suspected or Proven Malignant Solid Tumors. Klinische Pädiatrie. 222(3). 199–202. 7 indexed citations
2.
Göbel, U., Gabriele Calaminus, Dominik T. Schneider, et al.. (2006). The Malignant Potential of Teratomas in Infancy and Childhood: The MAKEI Experiences in Non-Testicular Teratoma and Implications for a New Protocol. Klinische Pädiatrie. 218(6). 309–314. 18 indexed citations
3.
Calaminus, Gabriele, M. Bamberg, D. Harms, et al.. (2005). AFP/β-HCG Secreting CNS Germ Cell Tumors: Long-Term Outcome with Respect to Initial Symptoms and Primary Tumor Resection. Results of the Cooperative Trial MAKEI 89. Neuropediatrics. 36(2). 71–77. 71 indexed citations
4.
Moorman, Anthony V., S Raimondi, C-H Pui, et al.. (2005). No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities. Leukemia. 19(4). 557–563. 15 indexed citations
5.
Boer, Monique L. den, D. Harms, Rob Pieters, et al.. (2003). Patient Stratification Based on Prednisolone-Vincristine-Asparaginase Resistance Profiles in Children With Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 21(17). 3262–3268. 133 indexed citations
6.
Stadt, Udo zur, D. Harms, Martin Schrappe, et al.. (2001). MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen. Leukemia. 15(2). 283–285. 22 indexed citations
7.
Stadt, Udo zur, D. Harms, Norbert Jorch, et al.. (2000). Minimal Residual Disease Untersuchungen bei der akuten lymphatischen Leukämie im Kindesalter im Rahmen der COALL-Studie: Ergebnisse einer Induktionstherapie ohne Asparaginase. Klinische Pädiatrie. 212(4). 169–173. 5 indexed citations
8.
9.
10.
Niehues, Tim, Petra Kapaun, D. Harms, et al.. (1999). A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies. Leukemia. 13(4). 614–617. 40 indexed citations
11.
12.
Janka‐Schaub, G., D. Harms, Ulrich Goebel, et al.. (1996). Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood — follow up after 9 years. European Journal of Pediatrics. 155(8). 640–648. 13 indexed citations
13.
14.
Göbel, U., M. Bamberg, Rainer Haas, et al.. (1989). Nichttestikuläre Keimzelltumoren: Analyse der Therapiestudie MAKEI 83/86 und Protokolländerungen für die Nachfolgestudie. Klinische Pädiatrie. 201(4). 247–260. 4 indexed citations
15.
Jürgens, Heribert, Jürgen Dunst, D. Harms, et al.. (1988). Die GPO cooperativen Ewing-Sarkom Studien CESS 81/86:. Klinische Pädiatrie. 200(3). 243–252. 39 indexed citations
16.
Schmidt, D. & D. Harms. (1985). Fibromatosis of Infancy and Childhood. European Journal of Pediatric Surgery. 40(1). 40–46. 17 indexed citations
17.
Göbel, U., Rainer Haas, D. Harms, et al.. (1983). Behandlungsstrategie für nichttestikuläre maligne Keimzelltumoren bei Kindern und Jugendlichen - Konzept der kooperativen Therapiestudie MAKEI 83 der GPO*. Klinische Pädiatrie. 195(3). 201–206. 8 indexed citations
18.
Harms, D. & Jacob A. Lohr. (1978). [Inguinal Wilms' tumor (author's transl)].. PubMed. 190(1). 54–6. 7 indexed citations
19.
Harms, D.. (1978). [Roentgenographic changes of the skeleton in a case of tuberous sclerosis (morbus Bourneville-Pringle) (author's transl)].. PubMed. 190(2). 196–202. 1 indexed citations
20.
Manzke, H, D. Harms, & Klaus Dörner. (1971). [Treatment of congenital hyperuricemia].. PubMed. 119(7). 424–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Spaar Breakdown of academic impact, for papers by Mark Nesbit Breakdown of academic impact, for papers by Robert E. Hittle Breakdown of academic impact, for papers by Jacques Otten Breakdown of academic impact, for papers by F. B. Ruymann Breakdown of academic impact, for papers by Yasunori Toyoda Breakdown of academic impact, for papers by Batia Stark Breakdown of academic impact, for papers by Marilyn Sonley Breakdown of academic impact, for papers by Rebecca Byrd Breakdown of academic impact, for papers by Monika Csóka
Rankless by CCL
2026